Treatment of Ovarian Cancer First Line Chemotherapy or Targeted Therapy for Recurrent Cases

Abstract

Ovarian cancer is the seventh most common gynecological cancer worldwide, ovarian cancer is the eighth leading cause of cancer death in women. In recent years, the number of ovarian cancer cases has been increasing in Japan, more than 9,000 women are diagnosed with ovarian cancer each year. The 5 year survival rate is 58 , the lowest among gynecological cancers, 4,758 ovarian cancer deaths in 2012. That is, it is reported that about one in two ovarian cancer patients has died. Because it is difficult to cure recurrent ovarian cancer, treatment is used to prolong life and improve quality of life. Because PARP inhibitors are oral targeted drugs that specifically act on cancer cells, they are expected to reduce the risk of disease progression and death while maintaining a good safety profile. In this way, the development of oral preparations has made it possible to avoid the burden on patients such as pain caused by conventional injections and the time constraints required for infusion. In this review, we discuss new treatments for ovarian cancer. Takuma Hayashi | Kaoru Abiko | Ken Yamaguchi | Junzo Hamanishi | Masaki Mandan | Ikuo Konishi "Treatment of Ovarian Cancer: First-Line Chemotherapy or Targeted Therapy for Recurrent Cases" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-3 , April 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30470.pdf Paper Url :https://www.ijtsrd.com/medicine/other/30470/treatment-of-ovarian-cancer-firstline-chemotherapy-or-targeted-therapy-for-recurrent-cases/takuma-hayashi

Authors and Affiliations

Takuma Hayashi | Kaoru Abiko | Ken Yamaguchi | Junzo Hamanishi | Masaki Mandan | Ikuo Konishi

Keywords

Related Articles

Alarm System for Medicine Reminder Based on Microcontroller

This paper investigates based on microcontroller medicine reminder alarm system. This system includes the DS1307 Real Time Clock RTC module, L298N motor driver, DC motor, I2C Liquid Crystal Display LCD module, four pushb...

Ischemic Brain Vascular Accident Acute Phase Management

Objective To address, in a practical way, the acute treatment of ischemic cerebrovascular accident CVA based on the scientific recommendations latest. Methods A bibliographic search was performed in the PubMed, Scopus, S...

School Environment and Inclusive Educational Settings: Policy Implications and Mitigation Strategies Emerging from the South West Region of Cameroon

The Cameroon government have not enforced Full-service schools to provide quality education to all learners through flexibility to meet the full range of learning needs. Full-service schools are institutions that strive...

An Identity-Based Mutual Authentication with Key Agreement

Now days mobile networks are rapid development by performing the e-commerce transaction such as online shopping, internet banking and e- payment. So that to provide secure communication, authentication and key agreement...

The Impact of Spiritual Health Care on Patients’ Clinical Outcome

MethodA systematic literature review was conducted to determine the definition of spirituality and the impact of spiritual health care on HIV AIDS Patients’ response to treatment. We conducted an internet search using th...

Download PDF file
  • EP ID EP686137
  • DOI -
  • Views 103
  • Downloads 0

How To Cite

Takuma Hayashi, Kaoru Abiko, Ken Yamaguchi, Junzo Hamanishi, Masaki Mandan (2020). Treatment of Ovarian Cancer First Line Chemotherapy or Targeted Therapy for Recurrent Cases. International Journal of Trend in Scientific Research and Development, 4(3), -. https://europub.co.uk/articles/-A-686137